Delivery Order SPE2DB22D6029-SPE2DB24FT9ZB
- Not listed
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $25,113.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 17, 2022 and was awarded on May 16, 2022. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $28,487.20 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price of $14,688.33 and a period of performance through February 13, 2024. This award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $5,879.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 16, 2022, with a completion date of March 17, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite...
- The federal contract award is for the delivery of Myrbetriq ER 25 MG tablet (30 tablets per package) by Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award, valued at $1,195.33, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp as a prime contractor. This is a firm fixed price delivery order contract with a performance period through March 27, 2024. The contract does...
- This federal contract award is for the delivery of the pharmaceutical product Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract was awarded on January 13, 2022, with a ceiling value of $13,787.49 and a completion date of January 14, 2022. This is a delivery order contract with a firm fixed price pricing...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets in quantities of 90 to the Defense Logistics Agency (DLA). The $16,266.61 firm-fixed-price delivery order was awarded on March 21, 2022 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of March 22, 2022 and was not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract with the...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC enables Amerisourcebergen to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,249.47, is a firm fixed-price delivery order with a completion date of November 8, 2022. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $98,664.77 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FT9ZBDelivery Order
This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order valued at $2,141.00, with a firm fixed price and a completion date of February 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. has a smaller $750,000.00 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/12/24 |